Inventor
SINGH RESHMA
US16 patents
⚠️ This page may combine multiple inventors who share the name “SINGH RESHMA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
8 patentsUS10174095B2Jan 8, 2019
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
NOVARTIS AG41 citations96
US9777061B2Oct 3, 2017
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG85 citations96
US11084880B2Aug 10, 2021
Anti-BCMA chimeric antigen receptor
NOVARTIS AG15 citations93
US11413340B2Aug 16, 2022
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy
NOVARTIS AG2 citations72
US10568947B2Feb 25, 2020
Treatment of cancer using a CLL-1 chimeric antigen receptor
NOVARTIS AG6 citations71
US12186278B2Jan 7, 2025
Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy
NOVARTIS AG0 citations62
US12338287B2Jun 24, 2025
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG0 citations61
US10851166B2Dec 1, 2020
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG1 citations61
UNIV PENNSYLVANIA
4 patentsUS7820180B2Oct 26, 2010
Listeria-based and LLO-based vaccines
UNIV PENNSYLVANIA25 citations92
US7794729B2Sep 14, 2010
Methods and compositions for immunotherapy of cancer
UNIV PENNSYLVANIA23 citations92
US7662396B2Feb 16, 2010
Compositions and methods for enhancing the immunogenicity of antigens
UNIV PENNSYLVANIA30 citations87
US12214037B2Feb 4, 2025
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor
UNIV PENNSYLVANIA0 citations61